glp 1 drugs and gastroparesis New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events Gastroparesis: Symptoms, Causes, Diagnosis &
Description
These effects particularly are relevant in preventing adverse remodeling and heart failure progression [43]
Tirzepatide (Zepbound, Mounjaro) This is a dual-agonist medication, meaning it targets both GLP-1 and GIP receptors

Heise T, Mari A, DeVries JH, Urva S, Li J, Pratt EJ, Coskun T, Thomas MK, Mather KJ, Haupt A, et al

Currently, there are limited studies investigating the relationship between SLE and GLP-1RAs

Handles both loading doses and most maintenance doses for concentrations of 2.5 mg/mL and above

& Christensen, R
